Consortium members are expected to have access to the dataset by early 2027, and there are plans to add more complex antibody ...

Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...

The findings by scientists at NYU Abu Dhabi provide new insight into how cells respond when cancer-causing genes are ...

AI-guided structural modeling and proteomics identified molecular glues that degrade VAV1, a potential target in blood cancers and autoimmune diseases.

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

Nektar Therapeutics won its legal dispute with Eli Lilly over rezpegaldesleukin, but the court victory failed to deliver a ...

Researchers at the Nano Life Science Institute at Kanazawa University in Japan say they have directly visualized how enzymes ...

A slow-release liposome system delivered local anesthesia for weeks in rats, potentially enabling new approaches to pain ...

The results of a study by researchers at Texas Children’s Duncan Neurological Research Institute (Duncan NRI), at Baylor ...

Researchers hope findings could help lead to strategies for creating stem cell-derived dopamine-producing neurons that can be ...

In his new book "Curved Air", Kevin Davies, PhD, portrays the fascinating story of sickle cell disease, from its origins in ...

JNC is using BPI 2026 to spotlight Cellufine and its emerging MLP chromatography media, developed to address purification ...